Trial Profile

Effects of ivabradine on cardiovascular events in patients with moderate-to-severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 27 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Apr 2023 Results of post-hoc analysis assessing the clinical significance of the time durations of heart rate reduction and the significant treatment effect on outcomes among patients with heart failure and reduced ejection fraction, published in the European Journal of Heart Failure.
27 Feb 2021 Results of meta-analysis of 6 studies, published in the Clinical Cardiology.
18 Nov 2019 Results assessing impact on the outcome adjudication of the Systolic Heart failure treatment, presented at the American Heart Association Scientific Sessions 2019.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com